Abiopharma

🔍 Li Dean Y (Director)

Company: RECURSION PHARMACEUTICALS, INC. (RXRX)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 2,381 shares of Class A Common Stock (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,240,909.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-01-02 | Code: H | nature_of_ownership: By Dean Y. Li Revocable Trust | shares_owned_after: 1,422,048.00
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-01-02 | Code: H | nature_of_ownership: By Dean Y. Li GRAT | shares_owned_after: 136,981.00
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-01-02 | Code: H | nature_of_ownership: By Dean Y. Li 2021 Family Trust | shares_owned_after: 421,000.00

Footnotes:

• F1: The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.